Tesis Labs LLC Valuation, Funding & Investors

Tesis Labs LLC is valued at $520M as of September 2021.

Last Tesis Labs LLC valuation

$520M

Undisclosed stage · Sep 2021

Last Tesis Labs LLC funding round

$16M

Undisclosed stage · Jan 2022

Cumulative funding Tesis Labs LLC raised

$40M

across 4 funding rounds

Tesis Labs LLC Overview

About Tesis Labs LLC

Tesis Labs LLC is a Montevideo, Uruguay-headquartered developer of healthcare management software deployed in clinics across Latin America. Its platform streamlines electronic health records, telemedicine consultations, and billing for over 100 facilities. Tesis Labs integrates with national health systems for real-time patient data exchange.


Founded

2019

HQ

United StatesPhoenix, AZ

Status

Privately held

Customer focus

B2B

Revenue model

Subscription

Valuation

$520M (Sep 2021)

Tesis Labs LLC Valuation

Tesis Labs LLC is currently valued at $520M, based on its undisclosed-stage round in September 2021.

Tesis Labs LLC's valuation has moved from $520M at its seed round in July 2020 to $520M in September 2021, across 2 priced rounds.

Tesis Labs LLC valuation by funding round

Tesis Labs LLC valuation by funding round
DateStageValuation
Sep 2021Undisclosed stage$520M
Jul 2020Seed$520M

Tesis Labs LLC Funding History

Tesis Labs LLC has raised a total of $40M across 4 funding rounds.

Tesis Labs LLC's first fundraising round was a $1M seed round in December 2019. The most recent completed round was a $16M undisclosed-stage round in January 2022.

Tesis Labs LLC funding rounds

Tesis Labs LLC funding rounds
DateStageRaisedValuationDeal Summary
Jan 2022Undisclosed stage$16M--
Sep 2021Undisclosed stage$20M$520MTesis Labs LLC, a Phoenix-based biotech startup founded in early 2020, specializes in targeted genetic sequencing and precision medicine, providing healthcare providers with genetic testing tools to create personalized care plans for chronic diseases like heart disease, lung disease, and cancer. The company focuses on next-generation sequencing (NGS) testing with proprietary molecular panels and supports clinical research initiatives for preventative medicine and population health. On approximately September 30, 2021, Tesis Labs raised $20 million in its first external growth equity financing round, led by Xcellerant 1 TLC, LLC, an investment group headed by Arizona health entrepreneur John Shufeldt, MD. This Series A round achieved a post-money valuation of $520 million. Prior to this, the company had bootstrapped approximately $15 million from internal sources. The funding enables Tesis Labs to expand testing capacity significantly, including growing its labs in Denver, Lafayette (Colorado), and Houston, and opening a new facility in Scottsdale, Arizona, in December 2021, which alone would more than double current capacity. Plans also include building additional facilities nationwide to meet rising customer demand from clinical joint venture partners. Tesis Labs' in-house R&D team develops advanced diagnostic panels to assist partners in clinical trials, validating therapies for early non-symptomatic recognition and streamlining go-to-market timelines. The company positions itself at the forefront of precision medicine through genetic integration across generations.
Jul 2020Seed$3M$520MTesis Labs LLC is a Phoenix, AZ-based company specializing in targeted genetic sequencing, offering healthcare providers and physicians access to genetic testing and precision medicine for personalized care plans targeting chronic diseases like heart disease, lung disease, and cancer. The company provides unique diagnostic panels using next-generation sequencing (NGS) to support clinical trials, validate therapies, and streamline workflows for partners. Tesis Labs raised $20 million in growth equity financing in October 2021 at a post-money valuation of $520 million, led by Xcellerant 1 TLC, LLC. This was the first external financing since operations began in early 2020, following approximately $15 million raised prior. Funds supported expansion of clinical capacity, production, and proprietary product validation. Later rounds included a $20 million filing in October 2021 and $16 million in January 2022.
Dec 2019Seed$1M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Tesis Labs LLC Competitors

Tesis Labs LLC competitors include listed companies like Chularat Hospital, Garofalo Health Care, Sikarin and Strata Critical Medical, and private ones like Neuberg Diagnostics and Harbor Health.

Public and private companies comparable to Tesis Labs LLC
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Chularat HospitalThailandThailandPublicly listed$251M$52M$525M2.0x
Garofalo Health CareItalyItalyPublicly listed$559M$83M$548M1.4x
SikarinThailandThailandPublicly listed$181M$47M$479M-
Strata Critical MedicalUnited StatesUnited StatesPublicly listed$197M($16M)$476M1.7x
Neuberg DiagnosticsIndiaChennaiPrivate$107M-$642M6.0x
Harbor HealthUnited StatesAustin, TXPrivate--$650M-

Tesis Labs LLC Public Comps

Tesis Labs LLC is still privately-owned, but its public comps include Chularat Hospital, Garofalo Health Care, Sikarin, Strata Critical Medical, Hermina Hospitals, M1 Kliniken, Integral Diagnostics, Community Health Systems, Al-Maidan Dental Clinic and Auna.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Chularat Hospital$251M$52M2.1x2.0x9.8x9.5x
Garofalo Health Care$559M$83M1.5x1.4x9.8x8.6x
Sikarin$181M$47M2.5x-9.7x-
Strata Critical Medical$197M($16M)2.3x1.7x(28.4x)16.4x
Hermina Hospitals$402M$104M2.1x1.9x8.1x7.5x
M1 Kliniken$420M$46M0.9x1.7x8.6x9.8x
Integral Diagnostics$561M$99M1.8x1.8x10.2x8.4x
Community Health Systems$12B$2B0.9x0.9x5.5x8.0x

This data is available for Pro users. Sign up to see all Tesis Labs LLC competitors and their valuation data.

Start Free Trial

Common questions about Tesis Labs LLC

When was Tesis Labs LLC founded?Tesis Labs LLC was founded in 2019.
Where is Tesis Labs LLC headquartered?Tesis Labs LLC is headquartered in Phoenix, AZ, United States.
Is Tesis Labs LLC publicly listed?No, Tesis Labs LLC is a private company.
What is Tesis Labs LLC's valuation?Tesis Labs LLC was last valued at $520M in its undisclosed-stage round in September 2021.
How much funding has Tesis Labs LLC raised?Tesis Labs LLC has raised $40M across 4 funding rounds.
What was Tesis Labs LLC's last funding round?Tesis Labs LLC's last funding round was a $16M undisclosed-stage round in January 2022.
Which companies are comparable to Tesis Labs LLC?Companies comparable to Tesis Labs LLC include Chularat Hospital, Garofalo Health Care, Sikarin, Strata Critical Medical, Neuberg Diagnostics and Harbor Health.

See companies similar to Tesis Labs LLC

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial